Omicron, a new SARS-CoV-2 variant: assessing the impact on severity and vaccines efficacy
The reply letter has been put forth in response to the comment made by Karthyayani Priya Satish entitled “India and the COVID-19 Vaccine.” The comment was made in context to our published work “Exploring the covid-19 vaccine candidates against SARS-CoV-2 and its variants: where do we stand and where...
| Published in: | Human Vaccines & Immunotherapeutics |
|---|---|
| Main Authors: | , |
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2022-01-01
|
| Subjects: | |
| Online Access: | http://dx.doi.org/10.1080/21645515.2022.2034458 |